Brain abscesses arise from a localized parenchymal infection, typically elicited by pyogenic bacteria such as Staphylococcus aureus . Despite improvements in detection and treatment strategies, brain abscesses continue to occur, with an increased prevalence in developing countries and immune-compromised patients. Adding to the seriousness of these infections is the recent emergence of antibioticresistant strains of bacteria, which are becoming more commonly associated with brain abscesses. Recent studies using a mouse experimental brain abscess model have revealed a complex role for Toll-like receptors (TLRs) in disease pathogenesis. Interestingly, TLR2 has limited impact on the innate immune response during the
acute stage of brain abscess formation induced by S. aureus but influences adaptive immunity. In contrast, mice deficient in MyD88, a central adapter molecule for the majority of TLRs in addition to the IL-1R and IL-18R, demonstrate severe defects in innate immunity coupled with exaggerated tissue destruction. It is envisioned that understanding the roles for TLRs in both resident CNS glia as well as infiltrating immune cells will provide insights into how the immune response to bacterial infection can be tailored to achieve effective pathogen destruction without inducing excessive bystander damage of surrounding noninfected brain parenchyma. A discussion of recent findings in this field is presented along with outstanding questions and the concept of a pathogen-necrosis-autoantigen triad for the amplification of TLR signaling is introduced. 
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Etiopathogenesis of Brain Abscess
Brain abscesses develop in response to localized infections in the parenchyma, leading to the formation of an encapsulated suppurative lesion. The main etiologic agents of brain abscess are the Streptococcal strains and Staphylococcus aureus , although a variety of organisms including Gram-negative bacteria and fungi have also been reported (Mathisen and Johnson 1997 ; Townsend and Scheld 1998 ; Bhand 2004 ; Prasad et al. 2006 ; Njambi et al. 2007 ; Kantarcioglu et al. 2008 ) . Brain abscesses can form by bacterial perforation of the thin bony structures separating the brain from neighboring sites of chronic infection occurring in the paranasal sinuses, middle ear, or upper molars. Other routes include seeding of the brain with bacterial emboli originating from systemic sites of infection (i.e., endocarditis or septicemia) (Mathisen and Johnson 1997) , where the frontal and temporal lobes are most commonly affected (McClelland et al. 1978 ; Carpenter et al. 2007) , penetrating trauma to the head, or following neurosurgery (Tenney 1986 ; Schliamser et al. 1988 ) . In addition, predisposing conditions such as congenital heart disease, hereditary hemorrhagic telangiectasia, or hemorrhagic or ischemic strokes have been associated with an increased incidence of brain abscess (Chen et al. 1995 ; Kumar 2000 ; Emmez et al. 2007 ; Sell et al. 2008) . From a therapeutic standpoint, the diagnosis of brain abscess can often be delayed since patients typically present with nondescript clinical symptoms, including fever, poorly localized headache, and nausea. A differential diagnosis that includes brain abscess is often not made until patients begin to demonstrate neurological signs such as seizures, hemiparesis, and/or cognitive decline. By this time, a considerable amount of time has elapsed allowing the infection to disseminate and destroy a large portion of brain parenchyma. Therefore, if the diagnosis is significantly delayed and/or proper treatment is not administered, brain abscesses represent a significant medical problem, with mortality rates ranging from 30 to 80%. A large percentage of patients who recover from brain abscesses experience long-term complications, including seizures, loss of mental acuity, and focal neurological defects (Mathisen and Johnson 1997) . The incidence of brain abscess is one in every 10,000 hospital admissions in the US of an infectious disease nature (Mathisen and Johnson 1997 ) and 1.3 per 100,000 persons worldwide (Nicolosi et al. 1991) . For unknown reasons, the prevalence of brain abscess in males is 2-3 times more frequent compared to females (McClelland et al. 1978 ; Nicolosi et al. 1991 ; Kao et al. 2003) . In underdeveloped countries, the disease incidence is higher and the source of infection typically originates from the ear or teeth due to poor sanitary conditions. In developed countries, improvements in health quality, advances in diagnostic tools, and treatment modalities improve infection outcome; however, the recent emergence of multi-drug-resistant microorganisms presents a new therapeutic challenge (Krcmery and Fedor-Freybergh 2007) . Indeed, several case reports have described the isolation of methicillin-resistant S. aureus (MRSA) from brain abscesses, revealing the increased incidence of antibiotic-resistant bacteria in recent years (Smith et al. 1997 ; Khan et al. 2000 ; Roche et al. 2003 ; Jones et al. 2004) . Moreover, immunosuppressive therapies employed for the treatment of tumors or following organ/bone marrow transplantation are associated with an increased prevalence of brain abscess formation often caused by commensal microorganisms (Calfee and Wispelwey 2000 ; Baddley et al. 2002 ; Hristea et al. 2007 ) . Collectively, these issues highlight the need for further studies to understand hostpathogen interactions during brain abscess development.
Experimental Brain Abscess Model
Despite the continued incidence of brain abscesses, as demonstrated by the vast number of case reports in the literature, experimental models examining basic scientific aspects of this disease are limited. Although pioneering data were provided by experimental models of brain abscess in the rabbit (Falconer et al. 1943) , dog (Britt et al. 1981 ) and rat (Winn et al. 1979 ; Flaris and Hickey 1992) , studies describing the nature of the ensuing CNS and peripheral immune responses were rare or not detailed. Our laboratory has developed an experimental brain abscess model to elucidate the importance of host immune factors in disease pathogenesis (Kielian et al. 2001a ,b; Baldwin and Kielian 2004 ; Kielian et al. 2004b) , which was adapted from a previously published model in the rat (Flaris and Hickey 1992) and utilizes S. aureus , one of the main etiologic agents of brain abscess in humans (Roche et al. 2003 ; Jones et al. 2004 ) (Mathisen and Johnson 1997 ; Townsend and Scheld 1998) . The mouse brain abscess model accurately reflects the course of disease progression in humans, providing an excellent model system to study immunological pathways influencing abscess pathogenesis and the effects of therapeutic agents on disease outcome. At the histological level, brain abscess is typified by a sequential series of pathological changes that have been elucidated using the experimental rodent models described in detail below (Flaris and Hickey 1992 ; Kielian and Hickey 2000 ; Kielian et al. 2001a Kielian et al. , b, 2004b . Staging of brain abscess in humans has been based on findings obtained during computed tomography (CT) or magnetic resonance imaging (MRI) scans. The early stage or early cerebritis occurs from days 1 to 3 and is typified by neutrophil accumulation, tissue necrosis, and edema. Microglial and astrocyte activation is also evident at this stage and persists throughout abscess development. The intermediate or late cerebritis stage occurs from days 4 to 9 and is associated with a predominant macrophage infiltrate. The final or capsule stage occurs from days 10 onward and is associated with lymphocytic infiltrates and the formation of a well-vascularized abscess wall, in effect sequestering the lesion and protecting the surrounding normal brain parenchyma from additional damage. It should be noted that these intervals represent general time frames that may deviate slightly depending on the colonizing pathogen and other host factors such as immune status or age. In addition to limiting the extent of infection, the immune response that is an essential part of abscess formation also destroys surrounding normal brain tissue. This is supported by findings in experimental models where lesion sites are greatly exaggerated compared to the localized nature of initial bacterial infection, reminiscent of an overactive immune response (Kielian et al. 2001a, b ; Baldwin and Kielian 2004) . This phenomenon is also observed in human brain abscess, where lesions can encompass a large portion of brain tissue, often spreading well beyond the initial focus of infection. Therefore, controlling the intensity and/or duration of anti-bacterial immune responses in the brain may allow for effective elimination of bacteria while minimizing damage to surrounding brain tissue. This may conceivably be achieved by regulating the extent of TLR activation during brain abscess development. For example, upon abscess sterilization, the presence of microbial debris such as cell wall fragments and/or bacterial DNA may serve as a continual trigger for TLR-mediated activation of resident glia and infiltrating immune cells. This would effectively culminate in prolonged cytokine/chemokine release that may exacerbate the destruction of normal surrounding brain parenchyma via bystander lysis. In effect, the brain immunologically "senses" an infection in the absence of viable bacteria, resulting in pathological inflammation. In addition, tissue necrosis that accompanies these infections likely liberates endogenous TLR ligands, in a socalled "pathogen-necrosis-autoantigen triad" that effectively amplifies TLR signaling to further exacerbate tissue damage. This concept is introduced in a later section of this chapter. However, these possibilities remain to be directly tested in the experimental brain abscess model.
Importance of TLRs in Glial Recognition of S. aureus
As previously mentioned, microglial and astrocyte activation ensues immediately following bacterial infection and persists throughout the various stages of brain abscess development. Both glial cell types are important for providing a first line of defense against microbes invading the CNS parenchyma. Astrocytes are strategically located at the blood-brain barrier, providing a mechanism to immediately sense pathogenic motifs. Based on its prevalence in human brain abscesses, we have focused our attention on characterizing the receptors responsible for eliciting glial activation and subsequent proinflammatory mediator production in response to S. aureus . We have primarily focused on the roles of TLR2 and the central adapter molecule MyD88 in these processes using primary glia isolated from TLR2 and MyD88 KO mice. A summary of the findings obtained with microglia and astrocytes is provided below.
TLR and Microglial Responses to S. aureus
Microglia are the resident professional mononuclear phagocyte population in the brain parenchyma, and function as the principal innate immune effector cells in the CNS (Aloisi 2001 ; Rivest 2003) . Upon pathogen recognition, resting microglia transform into activated cells that migrate and accumulate at sites of injury (Gonzalez-Scarano and Baltuch 1999 ; Gonzalez-Scarano and Martin-Garcia 2005) . Activated microglia express a range of genes related to inflammation, such as proinflammatory cytokines, proinflammatory enzymes, and adhesion molecules, which are dictated by the nature of the inflammatory stimulus (Gonzalez-Scarano and Baltuch 1999 ; Aloisi 2001 ; Block et al. 2007 ) . The pattern of inflammatory molecule production can dictate leukocyte migration across the blood-brain barrier (Persidsky et al. 1999 ) and promote the effector functions of these newly recruited cells. Recent studies have demonstrated the presence of mRNA and/or protein expression of TLRs 1-9 in microglia (Dalpke et al. 2002 ; Rasley et al. 2002a ; Kielian et al. 2002; Olson and Miller 2004) , and have shown that TLR levels are modulated following exposure to bacterial pathogens (Rasley et al. 2002a ; Kielian et al. 2002 ; Olson and Miller 2004 ; Esen and Kielian 2005) . These findings are, perhaps, not surprising considering that microglia share the same myeloid lineage as macrophages and dendritic cells-important anti-bacterial effector and antigenpresenting cells.
One well-characterized PAMP of S. aureus is peptidoglycan (PGN), a major component of the bacterial cell wall (Dziarski 2003 ; Weber et al. 2003) . Although recently scrutinized, PGN is still considered a potent TLR2 agonist (Dziarski and Gupta 2005) . With regard to brain abscess, PGN is released during normal bacterial growth as well as from dying organisms within the necrotic environment that is typical of these infections. In addition, many antibiotics that are used to treat CNS Gram-positive infections enhance PGN release from the bacterial cell wall (van der Flier et al. 2003 ; Weber et al. 2003) , liberating additional antigen to engage PRRs such as TLR2. Collectively, these findings indicate that PGN represents a PAMP of significant biological importance in brain abscess as well as other CNS Grampositive infections. Therefore, our in vitro studies have centered on the responses of glial cells to PGN as well as intact S. aureus , the latter of which presents glia with a more complex antigenic milieu and multiple TLR ligands (i.e., lipoproteins, bacterial DNA).
Our results have demonstrated that microglia respond to both intact S. aureus and its cell wall component PGN robustly. Specifically, exposure to both stimuli led to a dose-and time-dependent induction of the proinflammatory cytokines IL-1 β , TNF-α , IL-12 p40, and several chemokines including CXCL1 (KC), CXCL2 (MIP-2), CCL2 (MCP-1), CCL3 (MIP-1 α ), and CCL4 (MIP-1 β ) (Kielian et al. 2002 (Kielian et al. , 2004a (Kielian et al. , 2005a . The importance of microglia in the early host response to infection in brain abscess is suggested by the fact that proinflammatory mediator production is detected within 1-3 h following the initial S. aureus infection, well before the significant accumulation of peripheral immune cell infiltrates (Kielian and Hickey 2000 ; Esen et al. 2004) . Moreover, both heat-inactivated S. aureus and PGN are capable of inducing microglial MHC Class II, CD40, CD80, and CD86 expression (Kielian et al. 2002 (Kielian et al. , 2004a Esen and Kielian 2007) , similar to what has been described for microglia in response to the Gram-negative bacterial cell wall product lipopolysaccharide (LPS) and interferon-γ (IFN-γ ) (Frei et al. 1994 ; Xu and Ling 1995 ; Menendez Iglesias et al. 1997 ; Aloisi et al. 1998 ; O'Keefe et al. 2001 ) . The ability of S. aureus to augment the expression of receptors that are important for antigen presentation suggests that the ability of microglia to present bacterial peptides to antigen-specific T cells may be greatly enhanced following S. aureus exposure. The effects of S. aureus and PGN on microglial CD40, CD80, CD86, and MHC Class II expression may be either a direct consequence of bacterial stimulation or an indirect one via the autocrine/paracrine action of cytokines produced by activated microglia.
An analysis of the importance of TLR2 in mediating microglial responses to S. aureus revealed some interesting findings. Namely, primary microglia isolated from TLR2 KO mice were nonresponsive to S. aureus -derived PGN, demonstrating a pivotal role for TLR2-dependent signals in eliciting proinflammatory mediator release from microglia in response to this PAMP (Kielian et al. 2005a ) . In contrast, microglial activation following treatment with intact S. aureus was only marginally affected by TLR2 loss, with the majority of mediators expressed at roughly equivalent levels between TLR2 KO and WT primary microglia. Interestingly, we consistently observed elevated IL-12 p40 production by TLR2 KO microglia in response to intact S. aureus , suggesting dysregulated signaling pathways (Kielian et al. 2005a ) . Heightened IL-12 p40 expression was never detected in TLR2 KO microglia following PGN treatment, indicating antigenic specificity in cytokine regulation. The mechanism(s) responsible for this phenomenon are not known but are under investigation in our laboratory.
Unlike what was observed with TLR2, MyD88 expression was essential for eliciting proinflammatory mediator production from microglia in response to both intact S. aureus as well as PGN. This finding strongly suggests the involvement of alternative TLRs that recognize additional PAMPs present in S. aureus and/or amplification of signaling networks through the autocrine/paracrine actions of cytokines that utilize MyD88, such as the IL-1R and IL-18R. The importance of MyD88 in CNS resident cells has recently been demonstrated using radiation bone marrow chimera mice (Garg et al., 2009 ). Specifically, cytokine expression was restored to wild-type levels during brain abscess development only when MyD88 was present in the CNS. The absence of MyD88 in the CNS compartment, with expression restricted to infiltrating immune cells, was not sufficient to restore cytokine levels to that observed in wild-type mice. Although we cannot ascertain whether MyD88 is pivotal in microglia, astrocytes, and/or other CNS resident cell types, these data do indicate that CNS MyD88 is essential for generating a potent inflammatory response during brain abscess development.
Astrocytes and TLR2-dependent Recognition of S. aureus
Besides microglia, astrocytes can also participate in the immune response against CNS pathogens, in addition to their traditional roles in influencing CNS development and homeostasis. Indeed, activated astrocytes have been recognized as being a major source of inflammatory chemokines in response to diverse stimuli (Dong and Benveniste 2001 ; Farina et al. 2007 ) . Several reports have provided direct evidence for the presence of TLRs in astrocytes (Bsibsi et al. 2002 ; Bowman et al. 2003 ; Esen et al. 2004 ; Carpentier et al. 2005 ; Jack et al. 2005) ; however, the number of TLRs expressed is much lower compared to microglia, which may be explained by the fact that microglia are more classical innate immune effector cells. Primary murine astrocytes constitutively express low levels of TLR2, TLR3, TLR5 and TLR9, with the expression of each TLR homolog rapidly upregulated following exposure to its cognate bacterial ligand (Bowman et al. 2003 ; Carpentier et al. 2005) . Although some groups have reported that astrocytes express TLR4 (references 1-3 below), we and others have been unable to demonstrate receptor expression (references 4-6 below and Kielian, unpublished observations). These discrepancies may be due to signals arising from residual microglial contamination since these cells are notorious for hiding beneath astrocytic monolayers and remains an issue to be resolved.
With regard to S. aureus , astrocytes appear to rely heavily on TLR2 for signaling cell activation and subsequent proinflammatory mediator release. This was demonstrated by the finding that TLR2 KO astrocytes were relatively nonresponsive to either PGN or intact S. aureus (Esen et al. 2004) , the latter observation being a major discriminating factor between astrocytes and microglia that utilize alternative PRRs for maximal recognition of intact bacteria. Specifically, a wide array of proinflammatory cytokines and chemokines were attenuated in TLR2 and MyD88 KO astrocytes despite the fact that bacterial internalization was not affected by either molecule (Esen et al. 2004 ) (Esen and Kielian, manuscript in preparation) . As mentioned earlier, MyD88 plays an important role in the CNS compartment in eliciting a protective immune response during the acute stage of brain abscess development (Garg et al., 2009) . It is quite probable that astrocytes, in concert with microglia, contribute to this process. Since astrocytes represent a more robust source of chemokines compared to microglia, the loss of MyD88 in the former may have drastic implications on the recruitment of immune cells from the periphery into the infected CNS.
Cytokine Regulation of TLR2 Expression in Glia
We previously reported that exposure of microglia to S. aureus led to elevated TLR2 expression (Kielian et al. 2005a ) . However, it remained uncertain as to whether this phenomenon resulted from a direct effect of pathogen exposure or indirectly through the autocrine/paracrine action of cytokines released from activated cells. Indeed, microglia produce several inflammatory mediators following S. aureus stimulation, including TNF-α and IL-1 β (Kielian et al. 2002 (Kielian et al. , 2004a (Kielian et al. , 2005a . We recently demon-strated that the proinflammatory cytokine TNF-α enhances TLR2 expression in microglia, whereas interleukin-1 β (IL-1 β ) had no significant effect ) . Strong evidence implicating TNF-α as a pivotal mediator for augmenting TLR2 expression was demonstrated by the inability of TNF-α KO microglia to upregulate TLR2 following S. aureus stimulation ) . Direct in vivo evidence to support this concept was provided by the finding that TLR2 expression was significantly attenuated during brain abscess development in TNF-α KO mice. In addition, the TNF-α -dependent induction of TLR2 expression in microglia was mediated by a NF-κ B-dependent pathway, whereas PKC or p38 MAPK signals were not involved ) . Similar findings were obtained in astrocytes, where TNF-α was shown to act in an autocrine/paracrine fashion to augment TLR2 expression (Phulwani et al. 2008) . The ability of TNF-α to increase TLR2 levels was mediated by NF-κ B signaling since disparate inhibitors of this pathway were capable of interfering with TLR2 induction (Phulwani et al. 2008) . Collectively, these results suggest that TNF-α likely plays an important role in amplifying the immune responses of both microglia and astrocytes upon S. aureus exposure, in part by augmenting TLR2 expression.
Potential Contributions of Other TLRs to S. aureus Recognition by Glia
Our findings with TLR2 KO primary microglia suggested that other receptors are also involved in maximal S. aureus recognition. Indeed, this functional redundancy is not surprising since bacterial pathogens have the potential for devastating consequences in a tissue that has limited regenerative capacity such as the CNS. Possible alternative receptors could be TLR9, which recognizes nonmethylated CpG DNA motifs of microbes, or other cytoplasmic PRRs which may encounter PAMPs such as the cytosolic NOD2 protein which binds PGN (Inohara et al. 2003 ; Girardin et al. 2003a, b) . Alternatively, phagocytic scavenger receptors such as macrophage scavenger receptor type AI/AII (MSR) and lectin-like oxidized low-density lipoprotein receptor (LOX)-1 may play a role. Since the expression of LOX-1 is significantly increased in microglia following S. aureus exposure in vitro and in brain abscesses in vivo (Kielian et al. 2005a, b) , we suggest that scavenger receptors may be utilized by microglia to phagocytize and inactivate bacteria. More supporting evidence came with data showing that bacterial phagocytosis is opsonin-independent and does not require TLRs, since microglia lacking the central adapter molecule MyD88 were still capable of phagocytizing S. aureus (Esen and Kielian 2006 , and unpublished results). The implications of glial activation in the context of brain abscess are likely several-fold. First, parenchymal microglia and astrocytes are likely involved in the initial recruitment of professional bactericidal phagocytes into the CNS through their elaboration of chemokines and proinflammatory cytokines. Second, microglia exhibit modest S. aureus bactericidal activity in vitro, suggesting that they may also participate in the initial containment of bacterial replication in the CNS. However, their bactericidal activity in vitro is not comparable to that of neutrophils or macrophages, suggesting that this activity may not be a major effector mechanism for microglia during acute infection. Third, activated microglia have the potential to influence the type and extent of anti-bacterial adaptive immune responses through their upregulation of MHC Class II and co-stimulatory molecule expression. Finally, if glial activation persists in the context of ongoing inflammation, the continued release of proinflammatory mediators could damage surrounding normal brain parenchyma. Indeed, inappropriate glial activation has been implicated in several CNS diseases, including multiple sclerosis and its animal model experimental autoimmune encephalomyelitis, as well as Alzheimer's disease (Benveniste 1997 ; McGeer and McGeer 2002) .
Impact of TLR Signaling on Immune Responses During Brain Abscess Development
TLR2 has been shown to play an important role in the host immune response to Gram-positive bacterial infections in the periphery and, to some extent, this receptor dictates the ensuing host anti-bacterial response in Streptococcus pneumoniae meningitis (Echchannaoui et al. 2002 ; Koedel et al. 2003 ) (see the chapter "Toll-Like Receptors in Bacterial Meningitis" of this volume). However, prior to our studies, the functional role of TLR2 in the context of a CNS parenchymal infection, such as brain abscess, had not been examined and was thought to differ from that of meningitis based upon the highly focal nature of lesions in the former.
Influence of TLRs on Innate Immunity in Brain Abscesses
We first evaluated the expression of numerous proinflammatory mediators previously determined to be pivotal for the host immune response during the acute phase of brain abscess development to ascertain whether defects in CNS bacterial recognition were evident in TLR2-deficient animals. The kinetics of proinflammatory mediator production, including TNF-α , IL-1 β , CXCL2 and inducible nitric oxide synthase (iNOS), were delayed in TLR2 KO mice compared to WT animals, with lower levels of mediators detected in the former during the acute stage of disease (Kielian et al. 2005a, b) . However, the reduction in these inflammatory mediators was transient, with levels in TLR2 KO mice recovering to those detected in WT animals over time, and as such, no striking phenotype was observed in TLR2 KO mice, much to our surprise. However, one dramatic difference was consistently observed in brain abscesses of TLR2 KO animals, namely elevated IL-17 expression (Kielian et al. 2005b) . The potential biological impact of increased IL-17 levels in TLR2 KO mice will be discussed in a later section describing the interface of TLRs with the adaptive immune response. In addition, TLR2 did not play a significant role in controlling the extent of infection in brain abscess, with similar bacterial titers observed between TLR2 KO and WT animals, suggesting receptor redundancy for S. aureus neutralization in the CNS (Kielian et al. 2005a, b) . Interestingly, the inflammatory phenotype detected in TLR2 KO mice was nearly identical to that observed in CD14 KO animals (Kielian, unpublished observations) , strongly suggesting that these two receptors may cooperate in a multireceptor complex to facilitate pathogen recognition and the subsequent shaping of the inflammatory milieu during the acute stage of infection. These results were in accordance with our in vitro studies, implying a role for alternative receptor(s) in bacterial recognition and subsequent activation of glial cells (Esen et al. 2004 ; Kielian et al. 2005a) . It is worth noting that our findings with TLR2 KO mice in the experimental brain abscess model (Kielian et al. 2005b) are at odds with a recent report by Stenzel et al. (2008) . Specifically, Stenzel et al. noted that brain abscess size was exacerbated in TLR2 KO mice; however, bacterial burdens were only marginally increased (Stenzel et al. 2008 ) . Similar to our earlier report (Kielian et al. 2005b) , this group also observed that the induction of proinflammatory mediator expression was delayed in TLR2 KO animals but eventually achieved levels equivalent to WT mice (Stenzel et al. 2008) .
In contrast to studies with TLR2 KO mice, MyD88 plays an essential role during the early phase of brain abscess. In particular, MyD88 loss led to a significant increase in mortality rates, which correlated with the complete disruption of normal brain tissue architecture in the infected parenchyma ) . Concomitant with these outcomes was the inability to recruit significant numbers of neutrophils and macrophages into the brain parenchyma of MyD88 KO animals, the former representing a leukocyte population that we had previously demonstrated to be essential for S. aureus containment during the acute stage of brain abscess (Kielian et al. 2001a ) . Finally, MyD88 KO mice displayed significant decreases in the expression of numerous proinflammatory cytokines and chemokines, which likely contributed, in part, to the impaired leukocyte recruitment observed in KO animals ) . The dramatic phenotype observed during the early stage of brain abscess formation in MyD88 KO mice is likely influenced by the loss of multiple TLRs as well as signaling via the IL-1R and/or IL-18R. Indeed, earlier studies by our group demonstrated that IL-1 KO mice displayed more severe infection, as typified by increased bacterial burdens and alterations in inflammatory mediator production during brain abscess development (Kielian et al. 2004b ) . The relative role of IL-18 signaling is uncertain since no one has yet investigated the importance of IL-18 in the experimental brain abscess model.
MyD88-dependent signals also played an important role in regulating the extent of parenchymal damage during the acute stage of brain abscess development. Indeed, brain abscesses were grossly disseminated in MyD88 KO mice and often encompassed the entire injected hemisphere, whereas lesions were contained and well demarcated in WT animals at all time points examined ) .
A recent study by Stenzel et al. has demonstrated that the astrocytic intermediate filament protein GFAP is important for providing a barrier to restrict brain abscess expansion throughout the parenchyma (Stenzel et al. 2004 ) . Of note is the finding that in our studies, GFAP immunoreactivity was enhanced in MyD88 KO mice (Kielian, unpublished observations ), yet these animals had diffuse lesions with ill-defined borders. This result may reflect an attempt by astrocytes to sequester the lesion for effective bacterial containment; however, in the face of the dramatic defects in CNS innate immunity in MyD88 KO mice, this attempt is futile. The dramatic pathology observed in brain abscesses of MyD88 KO mice presents an excellent model system to test the efficacy of various novel antimicrobial therapies since it is reminiscent of a worst-case scenario clinically.
Neutrophil and macrophage accumulation into brain abscesses was significantly attenuated in MyD88 KO mice compared to WT animals ) . Importantly, this correlated with a dramatic decrease in the production of numerous chemokines in brain abscesses of the former. The number of abscessassociated neutrophils in MyD88 KO mice was more significantly affected compared to macrophages, which agreed with the finding that the expression of neutrophil chemokines (i.e., CXCL1, CXCL2) was more depressed compared to macrophage chemoattractants (i.e., CCL2, CCL3). Not only were the numbers of abscess-associated neutrophils and macrophages reduced in brain abscesses of MyD88 KO mice, but their activation status was also impaired. This was reflected by lower levels of several cytokines and chemokines including IL-6, TNF-α , CCL3, and CXCL10 produced by these cell types recovered from lesions of MyD88 KO mice. Collectively, these findings highlight the importance of MyD88-dependent signals in inducing the host innate immune response during S. aureus infection in the brain.
One intriguing and unexpected finding that surfaced during the course of our studies with MyD88 KO mice was the fact that bacterial burdens were equivalent in MyD88 KO and WT animals despite the dramatic inhibition of CNS innate immune responses in the former. This finding suggests that alternative mechanisms are responsible for controlling bacterial replication in the CNS parenchyma, since no role for TLRs was evident in our studies. Since TLRs are not phagocytic receptors, it may be expected that alternative PRRs are responsible for pathogen uptake and neutralization (Henneke et al. 2002 ; Underhill and Gantner 2004) . Some candidate receptors that may participate in regulating S. aureus burdens in the CNS parenchyma include members of the scavenger receptor family as well as opsonic receptors, including Fc and complement receptors (Husemann et al. 2002 ; Peiser et al. 2002) . Another possibility is that the extensive tissue damage observed in MyD88 KO mice leads to cell death via a mechanism that is independent of bacterial burdens per se. Perhaps with a longer infection period differences in bacterial burdens between MyD88 KO and WT mice would have become evident; however, this analysis was not feasible in our studies since the majority of KO animals did not survive beyond 48 h post-infection. An alternative explanation may be that the defective host immune response in MyD88 KO mice led to altered selective pressures on S. aureus that could conceivably modify the organism's virulence factor expression profile. In this case, bacteria may have switched on a cohort of genes that favored invasion and dissemination. We are currently investigating this possibility by performing transcriptional profiling of genes expressed by S. aureus in MyD88 KO and WT mice using Affymetrix GeneChips ® .
Relationship Between TLR2 and Adaptive Immunity in Brain Abscesses
Innate and adaptive immunity are linked, and recent evidence indicates that TLRdependent signaling leads to the initiation of adaptive immune responses (Hoebe et al. 2004 ; Pasare and Medzhitov 2005) . Indeed, our earlier studies demonstrating lymphocyte influx and generation of S. aureus -reactive lymphocytes in the brain abscess model (Kielian and Hickey 2000 ; Baldwin and Kielian 2004) as well as the induction of molecules involved in antigen presentation (Kielian et al. 2002 (Kielian et al. , 2004a Esen and Kielian 2007) have provided clues to the connection between innate and adaptive immunity in brain abscesses. One apparent link between the two processes was discovered when we detected elevated IL-17 levels in TLR2 KO mice during the early stages of primary infection (Kielian et al. 2005b) . In this scenario, attributing cytokine production to memory T cells appeared unusual since animals had not been infected earlier with S. aureus . However, we have previously reported the presence of a population of S. aureus -reactive T cells in the spleens of "naïve" mice under non-SPF conditions (Baldwin and Kielian 2004) . The origin of these S. aureus -specific lymphocytes is not known but may have arisen from routine pathogen exposure, since S. aureus is ubiquitous in nature, or from the restimulation of cross-reactive lymphocytes that are specific for a highly conserved epitope expressed on another bacterial pathogen. Therefore, it is conceivable that "endogenous" S. aureus -reactive memory T cells are recruited into the CNS during the early stages of brain abscess development and are responsible for subsequent IL-17 production. Indeed, we have recently demonstrated that the numbers of both CD4 + and CD8 + T cell infiltrates are enhanced in brain abscesses of TLR2 KO mice compared to WT animals . These findings are in agreement with a recent report by Stenzel et al. in the experimental brain abscess model (Stenzel et al. 2008) , providing further evidence that T cell dynamics are indeed altered in the infected CNS of mice lacking TLR2. It is worth noting that elevated Th17 influx in TLR2 KO animals appears to represent a nontraditional pathway since, although Th17 cells are present in the CNS of infected WT mice, they do not dominate the adaptive response as Th1 cells producing IFN-γ are also a significant component of the T cell infiltrate .
We have recently found that primary microglia and astrocytes express for IL-17R isoforms, namely IL-17RA and IL-17RC, although not at equivalent levels ). Specifically, IL-17RA and IL-17RC were more highly expressed in microglia compared to astrocytes, whereas neither receptor was further modulated by bacterial activation. Evidence to support the idea that increased IL-17 production in TLR2 KO animals represents a compensatory mechanism to counteract the observed delay in the production of neutrophil-attracting chemokines came with the observation that IL-17 induced the expression of the neutrophil chemoattractant CXCL2 in astrocytes , in accordance with several studies that report IL-17 as a potent stimulus for the production of neutrophil chemokines (Witowski et al. 2000 ; Maertzdorf et al. 2002 ; Ruddy et al. 2004a ) . In addition, IL-17 has been shown to be pivotal in the establishment of antimicrobial immunity, since IL-17 KO mice are more susceptible to systemic bacterial infections (Ye et al. 2001 ; Chung et al. 2002 Chung et al. , 2003 .
Since IL-17 has been reported to synergize with other proinflammatory cytokines such as TNF-α and IL-1 β in various cell types (Chabaud et al. 2001 ; Maertzdorf et al. 2002 ; Ruddy et al. 2004b ; Dong 2008) , we examined whether this relationship would hold true for glia. Although TNF-α and IL-1 β alone were capable of eliciting the production of a few inflammatory mediators by glia, the addition of IL-17 did not significantly alter the release of these factors ). Collectively, the limited response of glial cells to IL-17 stimulation suggests that the primary target of increased IL-17 levels in brain abscesses of TLR2 KO mice may be stimulation of alternative parenchymal cells and/or peripheral immune cells infiltrating the CNS. Evidence to support the latter has been provided by recent studies from our laboratory demonstrating synergistic effects of IL-17 in combination with TNF-α in primary macrophages. These cells are also relevant to brain abscess pathogenesis since macrophages represent a significant constituent of the inflammatory infiltrate in response to infection (Kielian 2004) . Importantly, only a select number of mediators were potentiated by IL-17 in the presence of TNF-α (i.e., CXCL2, CCL2), whereas others were not affected (i.e., IL-1 β , IL-12). Interestingly, we failed to detect any synergy with IL-17 and IL-1 β regardless of the concentrations examined, revealing specificity in the responses obtained. We cannot discount additional roles for IL-17 in other effector responses of microglia and astrocytes including phagocytosis, chemotaxis and/or increased responsiveness to other inflammatory signals. These remain areas of continued investigation in our laboratory.
Concept of a "Pathogen-Necrosis-Autoantigen Triad"
During brain abscess development, the resultant immune response (mediated, in part, via TLRs) leads not only to pathogen destruction but also bystander damage to surrounding CNS parenchyma by necrotic cell death. Further complicating the issue is the fact that bacteria express numerous virulence factors that can directly lead to cell death/lysis of mammalian cells. One example is the hemolysins produced by S. aureus that form transmembrane pores in mammalian cells leading to cell destruction by osmotic lysis. The end result of this necrotic damage is the release of self antigens, many of which would not typically be exposed to the extracellular milieu and available for uptake by antigen-presenting cells. Therefore, it is also possible that during brain abscess evolution TLRs play dual roles in ligand recognition. In addition, one is to facilitate the initial response to the inciting pathogen. Upon tissue destruction, TLRs may also recognize newly liberated self antigens as a result of necrosis, a series of events we have coined a "pathogennecrosis-autoantigen triad" (Fig. 1) . In this case, newly liberated self antigens may serve as direct triggers for TLRs and/or be internalized by antigen-presenting cells in the vicinity of the abscess (i.e., macrophages, dendritic cells, and microglia), whereupon they could conceivably stimulate autoimmune reactions. This "pathogen-necrosis-autoantigen triad" shares similarities with the proposed "fertile field" Fig. 1 Proposed pathogen-necrosis-autoantigen triad. With regard to brain abscesses induced by S. aureus , the pathogen induces microglia and astrocyte activation via engagement of several Toll-like receptors (TLRs) in addition to other receptors to elicit pro-inflammatory mediator release to combat the infection. However, this response also leads to extensive necrosis of the infected parenchyma, which is also facilitated by virulence factors produced by the bacterium. Necrosis leads to the release of self antigens (autoantigens) that would not typically be encountered in the extracellular milieu. It is plausible that some of these autoantigens (as of yet to be defined) serve as further triggers for TLR activation, effectively exacerbating inflammation and further bystander destruction to surrounding uninfected brain parenchyma concept for autoimmunity, involving molecular mimicry in concert with bystander activation (von Herrath et al. 2003) . However, it is imperative to point out that there is no evidence to date, either experimental or clinical, to indicate that patients who have recovered from brain abscess exhibit increased prevalence of subsequent autoimmune disease, although it is likely that no one has investigated this relationship with retrospective studies. Although it is clear that self antigens are liberated during brain abscess development as a result of necrosis, what is not certain is whether this primes an individual for downstream autoimmunity. It could very well be that the liberation of self antigen during disease serves as a trigger for further TLR activation (via endogenous TLR agonists), which merely contributes to the inflammatory foci without inducing long-lasting overt consequences.
Summary
Despite recent studies investigating the importance of TLR2 and MyD88 in regulating host immune responses during brain abscess development, several outstanding questions remain. For example, studies with TLR2 KO microglia and in the experimental brain abscess model have clearly demonstrated the presence of alternative redundant pathways for bacterial recognition. This was initially unexpected given the importance of TLR2 in S. aureus sepsis (Takeuchi et al. 2000) ; however, upon closer examination this may be a dose-dependent effect, since severe pathology was not observed systemically unless TLR2 KO mice were challenged with high numbers of bacteria (Takeuchi et al. 2000) . Nonetheless, the identities of alternative receptors involved in S. aureus recognition in the CNS remain to be defined. Another unresolved issue is the functional importance of IL-17 during brain abscess development and, most importantly, whether IL-17 neutralization will reverse the proposed compensatory effect of elevated cytokine expression in brain abscesses of TLR2 KO mice. These are questions that are currently under investigation in our laboratory. Collectively, the TLR family of molecules likely influences a wide array of inflammatory responses during the course of brain abscess development, impacting both the innate and adaptive arms of the immune system.
